0001628280-20-017551.txt : 20201216 0001628280-20-017551.hdr.sgml : 20201216 20201216135531 ACCESSION NUMBER: 0001628280-20-017551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strauss David Eric CENTRAL INDEX KEY: 0001799869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 201392004 MAIL ADDRESS: STREET 1: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_160814491662278.xml FORM 4 X0306 4 2020-12-15 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001799869 Strauss David Eric C/O BELLICUM PHARMACEUTICALS, INC. 611 GATEWAY BLVD., SUITE 820 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr Director, Corp Controller Stock Option (right to buy) 2.97 2020-12-15 4 A 0 35000 0 A 2030-12-14 Common Stock 35000.0 35000 D 50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter. /s/ David E. Strauss 2020-12-16